{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,5,29]],"date-time":"2026-05-29T23:44:16Z","timestamp":1780098256486,"version":"3.54.0"},"reference-count":8,"publisher":"Ovid Technologies (Wolters Kluwer Health)","issue":"1","content-domain":{"domain":["lww.com","ovid.com"],"crossmark-restriction":true},"short-container-title":[],"published-print":{"date-parts":[[2026,1]]},"abstract":"<jats:p>The most common primary orbital cancer in adults is orbital lymphoma. Lymphomas involving the orbit, eyelid, or conjunctiva are described as ocular adnexal lymphoma (OAL). OAL comprises 2% of non-Hodgkin lymphomas but around 8% of extranodal lymphomas. OAL can appear bilaterally in any region of orbit with systemic involvement or restricted to orbit\/adnexal region. When identifying systemic involvement from orbital lymphoma and other extranodal lymphomas, PET\/CT has been demonstrated to have a higher sensitivity than CT. The predominant subtype of OAL is mucosa-associated lymphoid tissue (MALT)-type lymphoma, followed by follicular lymphoma.<\/jats:p>","DOI":"10.1097\/rlu.0000000000005911","type":"journal-article","created":{"date-parts":[[2025,4,18]],"date-time":"2025-04-18T01:00:10Z","timestamp":1744938010000},"page":"e37-e41","update-policy":"https:\/\/doi.org\/10.1097\/lww.0000000000001000","source":"Crossref","is-referenced-by-count":1,"title":["A Compilation of Orbital and Ocular Adnexal Lymphomas on 18F-FDG PET\/CT"],"prefix":"10.1097","volume":"51","author":[{"given":"Moulish","family":"Reddy","sequence":"first","affiliation":[{"name":"Department of Nuclear Medicine"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-5999-3778","authenticated-orcid":false,"given":"Mudalsha","family":"Ravina","sequence":"additional","affiliation":[{"name":"Department of Nuclear Medicine"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Amit","family":"Kumar","sequence":"additional","affiliation":[{"name":"Department of Medical Oncology"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Vijaya","family":"Sahu","sequence":"additional","affiliation":[{"name":"Department of Ophthalmology, AIIMS, Raipur, CG, India"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Rutuja","family":"Kote","sequence":"additional","affiliation":[{"name":"Department of Nuclear Medicine"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Sonali","family":"Thakur","sequence":"additional","affiliation":[{"name":"Department of Nuclear Medicine"}],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"276","published-online":{"date-parts":[[2025,4,18]]},"reference":[{"key":"R1-20251210","article-title":"Rare presentation of orbital plasmablastic lymphoma with oral cavity involvement in an HIV-negative patient","volume":"2015","author":"Podder","year":"2015","journal-title":"Case Rep"},{"key":"R2-20251210","first-page":"227","article-title":"Plasmablastic lymphoma in the orbit: case report","volume":"27","author":"Valenzuela","year":"2008","journal-title":"Orbit Amst Neth"},{"key":"R3-20251210","doi-asserted-by":"crossref","first-page":"13","DOI":"10.1007\/s00277-004-0914-3","article-title":"Extranodal marginal zone B-cell lymphomas of mucosa-associated lymphoid tissue-type of the orbit and ocular adnexa","volume":"84","author":"Lee","year":"2005","journal-title":"Ann Hematol"},{"key":"R4-20251210","doi-asserted-by":"crossref","first-page":"501","DOI":"10.1182\/blood-2008-12-195453","article-title":"Extranodal marginal zone lymphoma of the ocular adnexa","volume":"114","author":"Stefanovic","year":"2009","journal-title":"Blood"},{"key":"R5-20251210","doi-asserted-by":"crossref","first-page":"750","DOI":"10.3390\/cancers14030750","article-title":"Is there a role for [18F]FDG PET-CT in staging MALT lymphoma?","volume":"14","author":"Cohen","year":"2022","journal-title":"Cancers"},{"key":"R6-20251210","doi-asserted-by":"crossref","DOI":"10.1136\/bcr-2012-006847","article-title":"Primary orbital non-Hodgkin\u2019s lymphoma","volume":"2012","author":"Amit","year":"2012","journal-title":"BMJ Case Rep"},{"key":"R7-20251210","doi-asserted-by":"crossref","first-page":"1078","DOI":"10.1182\/blood-2014-11-537522","article-title":"FDG PET-CT in follicular lymphoma: a case-based evidence review","volume":"125","author":"Smith","year":"2015","journal-title":"Blood"},{"key":"R8-20251210","doi-asserted-by":"crossref","first-page":"3875","DOI":"10.1182\/blood-2002-09-2778","article-title":"Utility of FDG-PET scanning in lymphoma by WHO classification","volume":"101","author":"Elstrom","year":"2003","journal-title":"Blood"}],"container-title":["Clinical Nuclear Medicine"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/journals.lww.com\/10.1097\/RLU.0000000000005911","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2025,12,10]],"date-time":"2025-12-10T13:00:54Z","timestamp":1765371654000},"score":1,"resource":{"primary":{"URL":"https:\/\/journals.lww.com\/10.1097\/RLU.0000000000005911"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2025,4,18]]},"references-count":8,"journal-issue":{"issue":"1","published-print":{"date-parts":[[2026]]}},"URL":"https:\/\/doi.org\/10.1097\/rlu.0000000000005911","relation":{},"ISSN":["0363-9762","1536-0229"],"issn-type":[{"value":"0363-9762","type":"print"},{"value":"1536-0229","type":"electronic"}],"subject":[],"published":{"date-parts":[[2025,4,18]]},"assertion":[{"value":"2025-01-11","name":"received","label":"Received","group":{"name":"publication_history","label":"Publication History"}},{"value":"2025-03-17","name":"accepted","label":"Accepted","group":{"name":"publication_history","label":"Publication History"}}]}}